RVL Pharmaceuticals plc Quarterly Operating Margin in % from Q4 2018 to Q2 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
RVL Pharmaceuticals plc quarterly/annual Operating Margin history and growth rate from Q4 2018 to Q2 2023.
  • RVL Pharmaceuticals plc Operating Margin for the quarter ending June 30, 2023 was -192 %, a 4.05% increase year-over-year.
  • RVL Pharmaceuticals plc annual Operating Margin for 2022 was -119 %, a 74.9% increase from 2021.
  • RVL Pharmaceuticals plc annual Operating Margin for 2021 was -473 %, a 44.8% decline from 2020.
  • RVL Pharmaceuticals plc annual Operating Margin for 2020 was -327 %, a 96.9% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -192 +8.09 +4.05% Apr 1, 2023 Jun 30, 2023
Q1 2023 -172 +24.9 +12.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -119 +354 +74.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -137 -554 -133% Jul 1, 2022 Sep 30, 2022
Q2 2022 -200 -1.44K -116% Apr 1, 2022 Jun 30, 2022
Q1 2022 -197 -724 -137% Jan 1, 2022 Mar 31, 2022
Q4 2021 -473 -146 -44.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 418 +529 Jul 1, 2021 Sep 30, 2021
Q2 2021 1.24K +1.23K +9207% Apr 1, 2021 Jun 30, 2021
Q1 2021 527 -1.16K -68.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -327 +10.3K +96.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -111 +37.7 +25.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 13.4 +113 Apr 1, 2020 Jun 30, 2020
Q1 2020 1.69K +1.73K Jan 1, 2020 Mar 31, 2020
Q4 2019 -10.6K -10.6K -28344% Oct 1, 2019 Dec 31, 2019
Q3 2019 -149 Jul 1, 2019 Sep 30, 2019
Q2 2019 -99.4 Apr 1, 2019 Jun 30, 2019
Q1 2019 -38.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 -37.4 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.